摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

16-甲基十七烷酸十六烷基酯 | 93919-02-9

中文名称
16-甲基十七烷酸十六烷基酯
中文别名
——
英文名称
hexadecyl isostearate
英文别名
isostearyl palmitate;Hexadecyl 16-methylheptadecanoate
16-甲基十七烷酸十六烷基酯化学式
CAS
93919-02-9;69086-01-7
化学式
C34H68O2
mdl
——
分子量
508.913
InChiKey
FBQVFXLUGAFMIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    16
  • 重原子数:
    36
  • 可旋转键数:
    31
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.97
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:3611d406aca2ecb3f913dd301b91f0b3
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1-十六烷醇异十八酸 在 ZrOCl2 hydrate 作用下, 以 1,2,3,4-四氢萘 为溶剂, 反应 24.0h, 以55%的产率得到16-甲基十七烷酸十六烷基酯
    参考文献:
    名称:
    WO2006/64685
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof
    申请人:TORRENT PHARMACEUTICALS LTD.
    公开号:US20030045554A1
    公开(公告)日:2003-03-06
    The invention discloses a new clause of a five membered heterocylic ring compounds of general formula 1 1 and its pharmaceutically or cosmetically acceptable salts, wherein R1, R2, R3, R4, R5, A, B, X and Y are as defined in the specification. The invention also discloses a process for preparation of these compound and their therapeutic and cosmetic applications particularly in the management of aging related and diabetic vascular complications. The compounds in question act by triple action of an AGE (Advanced Glycation Endproducts) breaker, AGE inhibitor and free radical scavenger which make them most suitable in different therapeutic and cosmetic applications. The invention also discloses pharmaceuticals and cosmetic compositions comprising these compounds and method of treatment of diseases caused by accumulation of AGE and/or free radicals in the body cells.
    本发明公开了一种新的通式11的五元杂环化合物及其药学或美容学可接受的盐,其中R1、R2、R3、R4、R5、A、B、X和Y在说明书中定义。本发明还公开了制备这些化合物及其治疗和美容应用的方法,特别是在管理与衰老相关和糖尿病血管并发症方面。所述化合物通过AGE(高级糖基化终产物)断裂剂、AGE抑制剂和自由基清除剂的三重作用发挥作用,使它们在不同的治疗和美容应用中最为适用。本发明还公开了包含这些化合物的药物和化妆品组合物以及治疗由体细胞中AGE和/或自由基积累引起的疾病的方法。
  • Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
    申请人:Torrent Pharmaceuticals Ltd
    公开号:EP1304101A1
    公开(公告)日:2003-04-23
    The invention discloses a new class of compounds particularly pyridinium derivatives, which have been found to exhibit triple function of a free radical scavenger (antioxidant), AGE breaker and AGE inhibitor, and cosmetic composition comprising these compounds contained in a cosmetically acceptable carrier. The invention also discloses a method of cosmetic application by applying such composition. The invention further discloses a pharmaceutical composition, comprising said compounds useful in scavenging free radicals from the body cells of a mammal, a method of scavenging free radicals from the body cells of a mammal and a method of treating of diseases caused by accumulation of free radicals in the body cells of a mammal by administering a composition made with the compounds of the invention. The invention in addition, also discloses composition and method for inhibiting AGE in a mammal by use of the compounds of the same group.
    本发明公开了一类新化合物,特别是吡啶鎓衍生物,它们被发现具有自由基清除剂(抗氧化剂)、AGE 破坏剂和 AGE 抑制剂的三重功能,还公开了包含在化妆品可接受载体中的这些化合物的化妆品组合物。本发明还公开了一种通过施用此类组合物进行美容的方法。本发明进一步公开了一种药物组合物,其中包含有助于清除哺乳动物体细胞中自由基的所述化合物;一种清除哺乳动物体细胞中自由基的方法;以及一种通过施用用本发明化合物制成的组合物治疗哺乳动物体细胞中自由基积累引起的疾病的方法。此外,本发明还公开了通过使用同组化合物抑制哺乳动物体内 AGE 的组合物和方法。
  • HETEROCYCLIC COMPOUNDS FOR AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS
    申请人:Torrent Pharmaceuticals Ltd
    公开号:EP1373263B1
    公开(公告)日:2004-10-27
  • US5972993A
    申请人:——
    公开号:US5972993A
    公开(公告)日:1999-10-26
  • US7223777B2
    申请人:——
    公开号:US7223777B2
    公开(公告)日:2007-05-29
查看更多